Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins

Antonella Antignani(National Institutes of Health), Craig J. Thomas(National Institutes of Health)
PLoS ONE
August 24, 2016
10.1371/journal.pone.0161415
Cited by 8

Related Papers

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
|Nature|2010|1.6k
Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein
|Proceedings of the National Academy of Sciences|2016|265
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
|Science Translational Medicine|2019|88